$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

$mlss Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000143774920024013 Filed on November 16, 2020

Income Statement

Concept	2020 Q3	2019 Q3
Revenue	$1.246M	$1.900M
YoY Change	-34.41%	17.11%
Cost Of Revenue	$409.6K	$523.7K
YoY Change	-21.78%	-69.95%
Gross Profit	$836.5K	$1.376M
YoY Change	-39.22%	-1244.84%
Gross Profit Margin	67.13%	72.44%
Selling, General & Admin	$2.275M	$2.315M
YoY Change	-1.71%	-19.79%
% of Gross Profit	272.0%	168.22%
Research & Development	$21.44K	$7.940K
YoY Change	170.0%	429.33%
% of Gross Profit	2.56%	0.58%
Depreciation & Amortization	$16.51K	$25.42K
YoY Change	-35.07%	-92.63%
% of Gross Profit	1.97%	1.85%
Operating Expenses	$2.313M	$2.323M
YoY Change	-0.42%	-47.53%
Operating Profit	-$1.477M	-$946.7K
YoY Change	55.98%	-79.18%
Interest Expense	-$570.00	-$1.899M
YoY Change	-99.97%	-123431.17%
% of Operating Profit
Other Income/Expense, Net		-$2.633K
YoY Change		47.59%
Pretax Income	-$1.477M	-$2.849M
YoY Change	-48.14%	-37.36%
Income Tax	$24.72K	$1.250K
% Of Pretax Income
Net Earnings	-$1.491M	-$2.837M
YoY Change	-47.44%	-35.42%
Net Earnings / Revenue	-119.65%	-149.33%
Basic Earnings Per Share	-$0.02	-$0.06
Diluted Earnings Per Share	-$0.02	-$0.06
COMMON SHARES
Basic Shares Outstanding	65.82M	47.72M
Diluted Shares Outstanding	65.82M	47.72M

Balance Sheet

Concept	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$14.45M	$1.711M
YoY Change	744.35%	312.52%
Cash & Equivalents	$14.45M	$1.711M
Short-Term Investments
Other Short-Term Assets	$527.1K	$559.7K
YoY Change	-5.84%	-54.73%
Inventory	$2.230M	$1.617M
Prepaid Expenses
Receivables	$963.0K	$1.239M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$18.89M	$5.756M
YoY Change	228.22%	-18.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.31K	$55.31K
YoY Change	-43.39%	-41.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$24.15K	$35.91K
YoY Change	-32.74%	33.59%
Total Long-Term Assets	$1.054M	$486.7K
YoY Change	116.51%	-14.61%
TOTAL ASSETS
Total Short-Term Assets	$18.89M	$5.756M
Total Long-Term Assets	$1.054M	$486.7K
Total Assets	$19.95M	$6.243M
YoY Change	219.51%	-18.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$666.1K	$739.7K
YoY Change	-9.95%	-43.38%
Accrued Expenses	$1.148M	$698.8K
YoY Change	64.24%	-65.11%
Deferred Revenue
YoY Change
Short-Term Debt	$276.2K	$0.00
YoY Change
Long-Term Debt Due	$7.900K
YoY Change
Total Short-Term Liabilities	$3.494M	$7.647M
YoY Change	-54.31%	16.23%
LONG-TERM LIABILITIES
Long-Term Debt	$30.62K	$0.00
YoY Change
Other Long-Term Liabilities	$576.4K
YoY Change
Total Long-Term Liabilities	$607.0K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.494M	$7.647M
Total Long-Term Liabilities	$607.0K	$0.00
Total Liabilities	$4.101M	$7.647M
YoY Change	-46.37%	16.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.81M	-$90.66M
YoY Change	10.09%	5.2%
Common Stock	$116.6M	$90.21M
YoY Change	29.29%	2.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$911.5K	$911.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares	$33.33K	$33.33K
Shareholders Equity	$15.92M	-$1.358M
YoY Change
Total Liabilities & Shareholders Equity	$19.95M	$6.243M
YoY Change	219.51%	-18.13%

Cashflow Statement

Concept	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$1.491M	-$2.837M
YoY Change	-47.44%	-35.42%
Depreciation, Depletion And Amortization	$16.51K	$25.42K
YoY Change	-35.07%	-92.63%
Cash From Operating Activities	-$2.235M	-$653.4K
YoY Change	242.0%	49.32%
INVESTING ACTIVITIES
Capital Expenditures	-$5.940K	-$1.820K
YoY Change	226.37%	-72.04%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$5.940K	-$1.820K
YoY Change	226.37%	-87.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	79.28K	28.87K
YoY Change	174.61%
NET CHANGE
Cash From Operating Activities	-2.235M	-653.4K
Cash From Investing Activities	-5.940K	-1.820K
Cash From Financing Activities	79.28K	28.87K
Net Change In Cash	-2.161M	-626.4K
YoY Change	245.06%	38.54%
FREE CASH FLOW
Cash From Operating Activities	-$2.235M	-$653.4K
Capital Expenditures	-$5.940K	-$1.820K
Free Cash Flow	-$2.229M	-$651.6K
YoY Change	242.04%	51.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q3	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	593625
CY2019Q4	mlss	Accrued Expenses Related Party AccruedExpensesRelatedParty	1057958
CY2020Q2	mlss	Acquisition Of Controlling Interest Equity Impact AcquisitionOfControllingInterestEquityImpact
CY2005Q1	mlss	Additional Percentage Of Director Compensation On Sales Value Using Certain Specify Technology AdditionalPercentageOfDirectorCompensationOnSalesValueUsingCertainSpecifyTechnology	0.025
CY2005Q1	mlss	Additional Percentage Of Director Compensation Sales Value Using Other Kind Of Technology AdditionalPercentageOfDirectorCompensationSalesValueUsingOtherKindOfTechnology	0.05
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	1133975
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodExercisePrice
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	6459000
	mlss	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	57750
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.87
	mlss	Class Of Warrant Or Right Exercised During Period Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodExercisePrice	0.50
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	mlss	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	mlss	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	1749171
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	2.01
	mlss	Class Of Warrant Or Right Issued During Period Exercise Price ClassOfWarrantOrRightIssuedDuringPeriodExercisePrice	0.50
	mlss	Class Of Warrant Or Right Reclassified During Period ClassOfWarrantOrRightReclassifiedDuringPeriod	376000
CY2019Q3	mlss	Common Stock Shares To Be Issued CommonStockSharesToBeIssued	2600000
	mlss	Credit From United Systems For Defective Handpieces CreditFromUnitedSystemsForDefectiveHandpieces
	mlss	Credit From United Systems For Defective Handpieces CreditFromUnitedSystemsForDefectiveHandpieces	-151562
	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	363956
CY2020Q3	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
CY2019Q4	mlss	Deferred Profit Related Parties Current DeferredProfitRelatedPartiesCurrent	340476
	mlss	Deferred Compensation Arrangement With Individual Shares Granted DeferredCompensationArrangementWithIndividualSharesGranted	1392460
	mlss	Expenses Paid Stock ExpensesPaidStock	644865
	mlss	Expenses Paid Stock ExpensesPaidStock	292915
CY2020Q3	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	2658
CY2019Q3	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses
	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses	7622
	mlss	Finance Lease Principal Payments Including Accrued Expenses FinanceLeasePrincipalPaymentsIncludingAccruedExpenses
CY2020Q3	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	1035362
CY2019Q4	mlss	Finitelived Intangible Assets Accumulated Impairment FinitelivedIntangibleAssetsAccumulatedImpairment	995603
CY2019Q3	mlss	Gain Loss On Issuance Of Shares To Be Issued GainLossOnIssuanceOfSharesToBeIssued	-680542
	mlss	Gain Loss On Issuance Of Shares To Be Issued GainLossOnIssuanceOfSharesToBeIssued	-674792
CY2020Q3	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1502014
CY2019Q3	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2849917
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6293169
	mlss	Income Loss From Continuing Operations Before Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4745454
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	-530659
	mlss	Increase Decrease In Accrued Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesRelatedParties	402905
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	12422
	mlss	Increase Decrease To Advances To Contract Manufacturer IncreaseDecreaseToAdvancesToContractManufacturer	-20289
	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	30175
	mlss	Noncash Operating Lease Expense NoncashOperatingLeaseExpense
CY2019Q4	mlss	Operating Lease And Finance Lease Liability Current OperatingLeaseAndFinanceLeaseLiabilityCurrent	15977
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-706071
	mlss	Operating Lease Right Of Use Asset Incurred OperatingLeaseRightOfUseAssetIncurred	-166292
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	706071
	mlss	Operating Lease Right Of Use Liability OperatingLeaseRightOfUseLiability	166292
CY2015Q2	mlss	Operating Leases Monthly Rent Expense OperatingLeasesMonthlyRentExpense	12522
	mlss	Percentage Of Valuation Allowance PercentageOfValuationAllowance	1
	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	768463
	mlss	Sharebased Compensation Bonus Paid In Stock SharebasedCompensationBonusPaidInStock	315425
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments
	mlss	Shares Issued To Consultants In Lieu Of Cash Payments SharesIssuedToConsultantsInLieuOfCashPayments	416500
CY2020Q2	mlss	Stock Issued During Period Value Employee Bonuses StockIssuedDuringPeriodValueEmployeeBonuses
CY2019Q2	mlss	Stock Issued During Period Value Mandatory Conversion Of Preferred Shares To Common Stock StockIssuedDuringPeriodValueMandatoryConversionOfPreferredSharesToCommonStock
CY2020Q1	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	230362
CY2020Q2	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	718650
CY2020Q3	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	36751
CY2019Q3	mlss	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	28875
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation
	mlss	Stock Issued Employees Compensation StockIssuedEmployeesCompensation	37500
	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering
	mlss	Stock Issued For Public Offering StockIssuedForPublicOffering	211500
	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors
	mlss	Stock Issued To Board Of Directors StockIssuedToBoardOfDirectors	67000
CY2020Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	171046
CY2020Q2	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	462504
CY2020Q3	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	9602
CY2019Q1	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	61500
CY2019Q3	mlss	Stock To Be Issued During Period Value Employee Bonuses StockToBeIssuedDuringPeriodValueEmployeeBonuses	150000
	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue
	mlss	Warrants And Rights Issued Intrinsic Value WarrantsAndRightsIssuedIntrinsicValue	560199
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P3Y
	mlss	Warrants And Rights Issued Weighted Average Remaining Term WarrantsAndRightsIssuedWeightedAverageRemainingTerm	P4Y127D
CY2019	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P4Y36D
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y266D
CY2018	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P76D
	mlss	Warrants And Rights Outstanding Weighted Average Remaining Term WarrantsAndRightsOutstandingWeightedAverageRemainingTerm	P2Y109D
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	666094
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1379425
CY2020Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	393090
CY2019Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	1358752
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	962983
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1710665
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1147698
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	775055
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	116577241
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	96082324
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30715
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23946
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18392
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39759
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	39760
CY2020Q3	us-gaap	Assets Assets	19945621
CY2019Q4	us-gaap	Assets Assets	6556289
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	56988
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44712
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	45147
CY2020Q3	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	723084
CY2019Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	710662
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	10000
CY2020Q3	us-gaap	Assets Current AssetsCurrent	18891789
CY2019Q4	us-gaap	Assets Current AssetsCurrent	6077171
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14448903
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1516272
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1516272
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	743429
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14448903
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1711249
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12932631
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	967820
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.50
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.95
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.55
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.49
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1074171
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6399196
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1592775
CY2019Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3284196
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63605119
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49410176
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63571786
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49376843
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	63605
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	49410
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
	us-gaap	Depreciation Depreciation	37159
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	409621
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	523672
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1024947
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1894550
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2375762
CY2018Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2470566
CY2020Q3	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2351727
CY2019Q3	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	2646346
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	387991
	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	1216680
	us-gaap	Depreciation Depreciation	35103
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16505
CY2019Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	25418
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74861
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	76919
CY2019Q3	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain	1200000
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain	1200000
CY2020Q3	us-gaap	Derivative Number Of Instruments Held DerivativeNumberOfInstrumentsHeld	0
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1846761
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2020Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	38527
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7903
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3904
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	30624
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4998
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P4Y109D
CY2019Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2020Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-342501
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-382260
CY2020Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1377863
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	342501
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	382260
CY2020Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax
CY2019Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-1899484
CY2020Q3	us-gaap	Gross Profit GrossProfit	836489
CY2019Q3	us-gaap	Gross Profit GrossProfit	1376149
	us-gaap	Gross Profit GrossProfit	2200223
	us-gaap	Gross Profit GrossProfit	4179030
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1477297
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2848667
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6266952
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4725577
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	49099
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24717
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1250
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26217
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	19877
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-965662
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-109989
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-713331
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-465670
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-747682
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-739195
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-100000
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	431917
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-50428
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-100000
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-50000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	609251
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-303989
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-11755
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	9027
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7996
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	90362
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-569
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2449
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8727
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-6067
CY2020Q3	us-gaap	Inventory Net InventoryNet	2229760
CY2019Q4	us-gaap	Inventory Net InventoryNet	1620509
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	354692
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	99885
CY2020Q3	us-gaap	Liabilities Liabilities	4101031
CY2019Q4	us-gaap	Liabilities Liabilities	4927642
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19945621
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6556289
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3494000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4927642
CY2020Q3	us-gaap	Minority Interest MinorityInterest	-78388
CY2019Q4	us-gaap	Minority Interest MinorityInterest	-67274
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19300229
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2253422
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21438
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9916
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6346160
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1275686
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-1490989
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-2836976
	us-gaap	Net Income Loss NetIncomeLoss	-6257668
	us-gaap	Net Income Loss NetIncomeLoss	-4661012
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-11025
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-12941
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35501
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35343
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	276180
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2020Q3	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	60
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	2313217
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	2322883
	us-gaap	Operating Expenses OperatingExpenses	8458448
	us-gaap	Operating Expenses OperatingExpenses	7051779
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1476728
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-946734
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6258225
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2872749
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	645341
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	68934
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12072
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	576407
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	30820
CY2019Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	39555
	us-gaap	Operating Lease Payments OperatingLeasePayments	78904
	us-gaap	Operating Lease Payments OperatingLeasePayments	118664
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	655870
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	15977
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y182D
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P146D
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	24150
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35905
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21438
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9916
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	527059
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	519063
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div>  Reclassifications</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Certain reclassification has been made to the <div style="display: inline; font-style: italic; font: inherit;">2019</div> financial statements to conform to the unaudited condensed consolidated <div style="display: inline; font-style: italic; font: inherit;">2020</div> financial statement presentation. These reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net loss or cash flows as previously reported.</div></div></div>
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18043284
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1974547
CY2019Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
CY2014Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	10000000
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	276180
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	985763
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	28875
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-1502014
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2849917
	us-gaap	Profit Loss ProfitLoss	-6293169
	us-gaap	Profit Loss ProfitLoss	-4696355
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-1612953
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-3178202
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-793195
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-1053243
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31311
	us-gaap	Share Based Compensation ShareBasedCompensation	76611
	us-gaap	Share Based Compensation ShareBasedCompensation	146847
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	44976
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21438
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7940
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	237089
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	109815
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-99806352
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-93524297
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1246110
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1899821
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3225170
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6073580
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	43242
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	663009
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2291779
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2314943
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8221359
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6941964
CY2019Q3	us-gaap	Share Price SharePrice	0.83
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15012
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7500
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	15000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	15922978
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1695921
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1628647
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	487829
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17008818
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15844590
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1528208
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2726502
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	837432
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1404744
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	33333
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	911516
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	911516
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4.</div>  Use of Estimates</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in determining the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to the allowance for doubtful accounts, inventory valuation, and cash flow assumptions regarding evaluations for impairment of long-lived assets and going concern considerations, and valuation allowances on deferred tax assets. Actual results could differ from those estimates.</div></div></div>
CY2019Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	956012
CY2020Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	880449
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	65817132
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47721732
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56478151
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43311984
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	65817132
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47721732
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56478151
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43311984

Files In Submission

Name	View Source	Status
0001437749-20-024013-index-headers.html	Edgar Link	pending
0001437749-20-024013-index.html	Edgar Link	pending
0001437749-20-024013.txt	Edgar Link	pending
0001437749-20-024013-xbrl.zip	Edgar Link	pending
ex_207001.htm	Edgar Link	pending
ex_207002.htm	Edgar Link	pending
ex_207003.htm	Edgar Link	pending
ex_207033.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mlss-20200930.xml	Edgar Link	completed
mlss-20200930.xsd	Edgar Link	pending
mlss-20200930_cal.xml	Edgar Link	unprocessable
mlss-20200930_def.xml	Edgar Link	unprocessable
mlss-20200930_lab.xml	Edgar Link	unprocessable
mlss-20200930_pre.xml	Edgar Link	unprocessable
mlss20200930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss

2020 Q3 Form 10-Q Financial Statement

#000143774920024013 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS MILESTONE SCIENTIFIC INC. Stock $mlss

2020 Q3 Form 10-Q Financial Statement

#000143774920024013 Filed on November 16, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLSS
MILESTONE SCIENTIFIC INC. Stock $mlss